Guide to Non-HDL Cholesterol

WRITTEN BY

The Levels Team

Updated: 05/22/2025|12 min read

Summary

Non-HDL cholesterol is a measurement of all the plaque-forming lipoproteins in your blood. It's calculated by subtracting HDL cholesterol from your total cholesterol value. You don't have to fast before a non-HDL cholesterol test.

Why It Matters

Non-HDL cholesterol represents not just "bad" cholesterol, known as LDL (low-density lipoprotein), but other atherogenic (plaque-forming) lipoproteins, including VLDL (very-low-density lipoprotein), IDL (intermediate-density lipoprotein), and lipoprotein(a).

While both non-HDL cholesterol and apolipoprotein B (ApoB) are markers that help assess cardiovascular risk, they measure different aspects of lipid metabolism:

• Non-HDL cholesterol testing measures the total amount of all atherogenic cholesterol-containing lipoproteins. It's a concentration measure (how much cholesterol is being transported).
• ApoB testing directly counts the number of atherogenic lipoprotein transport particles in your bloodstream, since exactly one ApoB particle attaches to each atherogenic particle.

This distinction is important because cardiovascular risk is more accurately assessed by the number of particles (measured by ApoB) than by the amount of cholesterol those particles carry (measured by non-HDL). Two people can have identical non-HDL cholesterol levels but different numbers of particles and, therefore, different actual risks.

Some experts consider non-HDL cholesterol a better marker for heart disease than LDL alone. One reason is that it is a more comprehensive risk assessment because it includes all the various types of unhealthy, plaque-building lipoproteins.

Another reason is that LDL calculations can be significantly affected by recent food intake, while non-HDL remains relatively stable regardless of fasting status, making it more practical for clinical use.

Associated Symptoms 

Non-HDL cholesterol is a laboratory finding rather than a medical condition itself. Elevated levels typically have no direct symptoms in early stages, making testing crucial for early detection of cardiovascular risk.

Common symptoms that may indicate advanced cardiovascular conditions associated with prolonged high non-HDL cholesterol:

• Chest pain or discomfort (angina): May occur during physical activity or stress when narrowed arteries can't deliver enough oxygen to the heart
• Shortness of breath: Can develop when heart function is compromised due to coronary artery disease
• Fatigue: May result from plaque buildup, reducing oxygen delivery to muscles and tissues
• Pain, numbness, or weakness in the legs when walking (claudication): Can indicate reduced blood flow to the lower extremities due to peripheral artery disease
• Heart palpitations or irregular heartbeat: Can occur when plaque in arteries blocks blood flow, damaging the heart muscle and disrupting the heart's electrical system

It's important to emphasize that cardiovascular disease associated with high non-HDL cholesterol often develops silently over decades before causing symptoms. By the time symptoms appear, significant arterial damage may have already occurred. This is why non-HDL testing and other preventative measures are valuable for detecting risk long before symptoms develop.

Clinical Ranges

Lab Reference Ranges:

• <20 Years: <120
• ≥20 Years: <130

Lifestyle Factors That Can Impact It

Activities that can positively impact non-HDL cholesterol levels include:

• Mediterranean diet: Rich in olive oil, nuts, fruits, vegetables, and fish, this diet reduces non-HDL cholesterol by providing healthy fats and antioxidants that improve lipid metabolism.
• Regular physical activity: Exercise helps clear atherogenic particles from the bloodstream and improves insulin sensitivity.
• Weight management: Losing excess weight reduces liver fat, improving lipid metabolism and lowering the production of VLDL particles.
• Limiting alcohol consumption: Moderate alcohol intake is associated with higher  HDL levels, indirectly affecting the non-HDL calculation, though excessive consumption worsens lipid profiles. 

Activities that can negatively impact non-HDL cholesterol levels include:

• High saturated and trans fat intake: These fats increase LDL and other unhealthy cholesterol.
• Smoking: Tobacco use causes oxidative stress and inflammation, which disrupts normal lipid metabolism.
• High-sugar diet: Having too much sugar increases triglyceride and VLDL production, significantly raising non-HDL cholesterol levels.

Other Factors That Can Impact It

Genetic Conditions

• Familial hypercholesterolemia (FH): Commonly caused by a mutation in genes controlling LDL receptor function prevent effective removal of LDL from the bloodstream, leading to elevated non-HDL cholesterol.
• ApoE gene variants: These affect how efficiently the body clears lipoproteins from circulation. 

Medical Conditions

• Hypothyroidism: Reduces LDL receptor activity and slows overall metabolism, decreasing the clearance of bad cholesterol.
• Chronic kidney disease: Disrupts normal lipoprotein metabolism and increases inflammation, leading to an unfavorable lipid profile.
• Diabetes mellitus: Causes insulin resistance, high triglycerides, low HDL, and increased VLDL particles.
• Metabolic syndrome: This is a cluster of conditions (central obesity, insulin resistance, hypertension, high triglycerides, and low HDL) that collectively raise non-HDL cholesterol levels.
• Liver disease: Impairs cholesterol metabolism, potentially affecting how lipoproteins are produced and cleared from the blood.

Medications and Supplements

These medications may decrease non-HDL cholesterol levels:

• Statins: The most effective medication class for lowering non-HDL cholesterol, reducing levels by 30-50% through inhibition of cholesterol synthesis
• Ezetimibe: Reduces non-HDL cholesterol by 15-20% by blocking intestinal cholesterol absorption
• PCSK9 inhibitors: Can lower non-HDL cholesterol by 40-60% by increasing LDL receptor availability
• Bile acid sequestrants: Reduce non-HDL cholesterol by 10-20% by binding bile acids in the intestine
• Fibrates: Primarily lower triglycerides, but can also modestly reduce non-HDL cholesterol
• Niacin: Can lower non-HDL cholesterol by 10-15% while raising HDL

These supplements may decrease non-HDL cholesterol levels. You should always speak with your doctor before using a supplement.

• Red yeast rice: Contains naturally occurring lovastatin-like compounds that inhibit cholesterol production, potentially lowering non-HDL by 15-25%
• Fish oil: Rich in omega-3 fatty acids that primarily reduce triglycerides but can also modestly lower non-HDL cholesterol by 5-10%
• Plant sterols/stanols: Block cholesterol absorption in the intestine, potentially reducing non-HDL by 5-15%
• Psyllium fiber: Forms a gel that binds bile acids and cholesterol in the digestive tract, potentially lowering non-HDL by 5-10%

Individual Factors

• Age: Non-HDL cholesterol typically rises until middle age.
• Sex: Premenopausal women generally have lower non-HDL cholesterol than men of the same age. After menopause, women's levels often rise and may exceed those of age-matched men.
• Pregnancy: Temporarily increases non-HDL cholesterol to support fetal development.
• Ethnicity: Some populations show different average values and responses to dietary interventions.

Testing Accuracy and Stability

Non-HDL cholesterol tests are generally reliable, but several factors can affect their accuracy.

Factors That Can Affect the Accuracy of Your Test

• Recent illness or inflammation
• Recent significant weight changes
• Seasonal variations (some people have higher levels in colder months)
• Recent high-fat meal (primarily affects triglycerides but may impact total cholesterol)

How It Relates to Other Markers

Other markers can provide insights about health status when viewed alongside non-HDL cholesterol. These tests may include:

• Complete Lipid Panel: Includes total cholesterol, LDL, HDL, and triglycerides, providing context for the non-HDL calculation.
• Apolipoprotein B (ApoB): Assesses the number of atherogenic particles.
• Lipoprotein(a): Elevated levels may suggest additional risk beyond traditional measures.
• High-sensitivity C-reactive protein (hs-CRP): A measure of inflammation, which plays a major role in the progression of atherosclerosis. It can help identify risk when combined with non-HDL cholesterol results.
• Glucose and HbA1c: Assess metabolic health and diabetes status.

What Results May Mean in the Context of Other Markers

• High Non-HDL + High LDL Cholesterol: Can indicate increased cardiovascular risk from multiple atherogenic lipoproteins.
• High Non-HDL + High Triglycerides: May indicate metabolic dysregulation, insulin resistance, or excess carbohydrate consumption.
• High Non-HDL + Low HDL: May represent a high-risk pattern associated with metabolic syndrome.

Follow-up Considerations

If your non-HDL cholesterol is abnormal, your provider may make some of the following recommendations. You should always speak to your doctor if you have medical questions or before making medical decisions.

When Re-Testing May Be Appropriate

• Confirm with repeat testing within 1-3 months
• After starting lipid-lowering therapy, retest in 4-12 weeks
• If results stabilize, retest annually
• Prior to stopping or changing medication to establish baseline before modification

Additional Testing Your Doctor May Consider

• Advanced lipoprotein testing: NMR spectroscopy or ion mobility to assess lipoprotein particle numbers and sizes.
• Liver function tests: To assess liver health before starting statins and to monitor during treatment.
• Thyroid function tests: To rule out hypothyroidism as a cause of abnormal results.
• Genetic testing: For suspected familial hypercholesterolemia when non-HDL is severely elevated.
• Coronary calcium scoring: To assess subclinical atherosclerosis and refine risk assessment in intermediate-risk patients.

When Additional Care May Be Warranted

• Extremely high non-HDL levels despite treatment
• Family history of premature cardiovascular disease combined with elevated non-HDL
• Development of side effects from lipid-lowering medications
• Presence of xanthomas (yellowish skin lesions) or other physical signs of severe dyslipidemia.
• Multiple cardiovascular risk factors

Bibliography